HOME     ABOUT US SERVICES STAFF MEMBERS RESEARCH ACTIVITIES PHOTO GALLERY
 
 
 
  .: Links
  WHO Collaborating Centre
  Products
  Toxicology Laboratory
  Publication/Production
  Collaborators
  News & Health Information
  Berita Kesihatan
  PRN Bulletins & Articles
  Malaysian Drug & Poison Net
  United For Tobacco Free
  Hiroshima On My Mind
  Articles by Founding Director
  Posters & Brochures
 
 
 
Contact Us
National Poison Centre
Universiti Sains Malaysia
11800 Penang
Malaysia
 
Tel: +604-657 0099
Fax: +604-656 8417
 
Email: prnnet@usm.my
 
 

HEALTH NEWS
Avastin boosts death risk in cancer patients
Source: The Star, February 3, 2011
   
 

Washington (U.S.A)  -  The cancer drug Avastin, also known as bevacizumab, is  linked to a higher risk of death when combined with chemotherapy, a study published in the Journal of the American Medical Association said.  The drug had been previously found to raise the risk of blood clots in the legs and lungs by 33 per cent.  Last December, the US Food and Drug Administration said it was neither safe nor effective against breast cancer.

Bevacizumab, marketed as Avastin by the Swiss drug giant Roche, was approved for use in combination with chemotherapy for treating colorectal cancer, non-small cell lung cancer and renal cell carcinoma.


   
     
  Back
   
 
 
 
 

 
 
Copyright © National Poison Centre, USM 2008. All Rights Reserved